NASDAQ:KROS

Keros Therapeutics (KROS) Earnings Date, Estimates & Call Transcripts

$49.15

-1.10 (-2.19%)

(As of 05/26/2023 08:47 PM ET)

Compare

Today's Range: $48.98
▼
$51.02
50-Day Range: $37.26
▼
$51.01
52-Week Range: $24.38
▼
$59.96

Volume: 160,300 shs
Average Volume: 204,260 shs
Market Capitalization: $1.45 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $103.75

Upcoming Earnings Date: Aug. 3Estimated
Actual EPS (May. 4): -$1.26 Missed By -$0.12
Consensus EPS (May. 4): -$1.14
Last Year's Q2 EPS (5/5/2022): -$1.01

Earnings Per Share Revenue

KROS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

KROS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Keros Therapeutics Analyst Forecasts

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2023	4	($1.23)	($1.00)	($1.14)
Q2 2023	4	($1.43)	($1.11)	($1.22)
Q3 2023	4	($1.50)	($1.18)	($1.27)
Q4 2023	4	($1.31)	($1.17)	($1.25)
FY 2023	16	($5.47)	($4.46)	($4.88)

KROS Earnings Date and Information

Keros Therapeutics last posted its earnings data on May 4th, 2023. The reported ($1.26) EPS for the quarter, missing the consensus estimate of ($1.14) by $0.12. Keros Therapeutics has generated ($4.40) earnings per share over the last year (($4.40) diluted earnings per share). Earnings for Keros Therapeutics are expected to grow in the coming year, from ($5.44) to ($5.43) per share. Keros Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 3rd, 2023 based off prior year's report dates.

Keros Therapeutics Earnings History by Quarter

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
8/3/2023 (Estimated)
5/4/2023	Q1 2023	($1.14)	($1.26)	($0.12)	($1.26)	$0.22 million
3/3/2023	Q4 2022	($1.12)	($1.09)	+$0.03	($1.09)
11/3/2022	Q3 2022	($1.26)	($0.92)	+$0.34	($0.92)
8/4/2022	Q2 2022	($1.07)	($1.13)	($0.06)	($1.13)
5/5/2022	Q1 2022	($0.86)	($1.01)	($0.15)	($1.01)	$4.50 million
3/9/2022	Q4 2021	($0.94)	($0.30)	+$0.64	($0.30)		$20.00 million
11/4/2021	9/30/2021	($0.72)	($0.87)	($0.15)	($0.87)
8/5/2021	6/30/2021	($0.66)	($0.67)	($0.01)	($0.67)		$0.10 million
5/6/2021	3/31/2021	($0.58)	($0.68)	($0.10)	($0.68)
3/24/2021	12/31/2020	($0.57)	($0.49)	+$0.08	($0.49)
11/10/2020	9/30/2020	($0.60)	($0.60)		($0.60)
8/13/2020	Q2	($0.6750)	($0.62)	+$0.0550	($0.62)
5/22/2020	Q1 2020	($0.37)	($5.11)	($4.74)	($5.11)

Keros Therapeutics Earnings - Frequently Asked Questions

When is Keros Therapeutics's earnings date?: Keros Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 3rd, 2023 based off last year's report dates. Learn more on KROS's earnings history.
Did Keros Therapeutics beat their earnings estimates last quarter?: In the previous quarter, Keros Therapeutics (NASDAQ:KROS) missed the analysts' consensus estimate of ($1.14) by $0.12 with a reported earnings per share (EPS) of ($1.26). Learn more on analysts' earnings estimate vs. KROS's actual earnings.

How much revenue does Keros Therapeutics generate each year?: Keros Therapeutics (NASDAQ:KROS) has a recorded annual revenue of $20.10 million.
How much profit does Keros Therapeutics generate each year?: Keros Therapeutics (NASDAQ:KROS) has a recorded net income of -$104.68 million. KROS has generated -$4.40 earnings per share over the last four quarters.
What is Keros Therapeutics's EPS forecast for next year?: Keros Therapeutics's earnings are expected to grow from ($5.44) per share to ($5.43) per share in the next year.

More Earnings Resources from MarketBeat

Related Companies:

Earnings Tools:

Earnings By Country:

Latest Articles:

This page (NASDAQ:KROS) was last updated on 5/29/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Keros Therapeutics (KROS) Earnings Date, Estimates & Call Transcripts

KROS Earnings Estimates and Actuals by Quarter

KROS Estimated and Actual Revenue by Quarter

Keros Therapeutics Analyst Forecasts

KROS Earnings Date and Information

Keros Therapeutics Earnings History by Quarter

Keros Therapeutics Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info

Keros Therapeutics (KROS) Earnings Date, Estimates & Call Transcripts

Earnings Summary

KROS Earnings Estimates and Actuals by Quarter

KROS Estimated and Actual Revenue by Quarter

Keros Therapeutics Analyst Forecasts

KROS Earnings Date and Information

Keros Therapeutics Earnings History by Quarter

Keros Therapeutics Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat